Filed: 8/14/2024ACC: 0001964437-24-000007
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $264.64M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$264.64M
Total AUM (reported)
12.44M
Total Shares
Allocation by class
COM$190.01M71.8%
SPONSORED ADR$43.05M16.3%
COM NEW$14.74M5.6%
SPONSORED ADS$8.30M3.1%
COM CL A$7.26M2.7%
CL A$1.28M0.5%
Portfolio Concentration
Top 3$71.77M27.1%
4–10$102.64M38.8%
11–25$88.95M33.6%
Rest$1.28M0.5%
Top 3 weight
27.1%
Top 10 weight
65.9%
Voting Authority Distribution
Total shares with voting rights: 12.44M
Sole
Full voting authority
12.44M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
ARGENX SE
SOLEShares64.20K
TypeSH
Market value$27.61M
10.43%
Sole
64.20K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares503.09K
TypeSH
Market value$22.67M
8.57%
Sole
503.09K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares479.68K
TypeSH
Market value$21.48M
8.12%
Sole
479.68K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares215.68K
TypeSH
Market value$16.29M
6.15%
Sole
215.68K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares113.22K
TypeSH
Market value$15.44M
5.83%
Sole
113.22K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares272.04K
TypeSH
Market value$14.74M
5.57%
Sole
272.04K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares178.59K
TypeSH
Market value$14.70M
5.56%
Sole
178.59K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.67M
TypeSH
Market value$14.11M
5.33%
Sole
1.67M
Shared
0.00
None
0.00
CARGO THERAPEUTICS INC
SOLEShares856.85K
TypeSH
Market value$14.07M
5.32%
Sole
856.85K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.13M
TypeSH
Market value$13.29M
5.02%
Sole
1.13M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares760.94K
TypeSH
Market value$12.46M
4.71%
Sole
760.94K
Shared
0.00
None
0.00
MERUS N V
SOLEShares164.77K
TypeSH
Market value$9.75M
3.68%
Sole
164.77K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares419.65K
TypeSH
Market value$8.62M
3.26%
Sole
419.65K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares627.76K
TypeSH
Market value$8.30M
3.14%
Sole
627.76K
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares1.11M
TypeSH
Market value$7.26M
2.74%
Sole
1.11M
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares713.54K
TypeSH
Market value$7.08M
2.67%
Sole
713.54K
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares249.61K
TypeSH
Market value$6.26M
2.36%
Sole
249.61K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares593.31K
TypeSH
Market value$6.11M
2.31%
Sole
593.31K
Shared
0.00
None
0.00
ITEOS THERAPEUTICS INC
SOLEShares367.43K
TypeSH
Market value$5.45M
2.06%
Sole
367.43K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares1.14M
TypeSH
Market value$5.09M
1.92%
Sole
1.14M
Shared
0.00
None
0.00
NEUMORA THERAPEUTICS INC.
SOLEShares390.08K
TypeSH
Market value$3.83M
1.45%
Sole
390.08K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares152.18K
TypeSH
Market value$3.56M
1.34%
Sole
152.18K
Shared
0.00
None
0.00
LONGBOARD PHARMACEUTICALS IN
SOLEShares71.44K
TypeSH
Market value$1.93M
0.73%
Sole
71.44K
Shared
0.00
None
0.00
RAPPORT THERAPEUTICS INC
SOLEShares70K
TypeSH
Market value$1.63M
0.62%
Sole
70K
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares47.66K
TypeSH
Market value$1.62M
0.61%
Sole
47.66K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARGENX SESOLE | SPONSORED ADR | 64.20K | SH | $27.61M 10.43% | 64.20K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 503.09K | SH | $22.67M 8.57% | 503.09K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 479.68K | SH | $21.48M 8.12% | 479.68K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 215.68K | SH | $16.29M 6.15% | 215.68K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 113.22K | SH | $15.44M 5.83% | 113.22K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 272.04K | SH | $14.74M 5.57% | 272.04K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 178.59K | SH | $14.70M 5.56% | 178.59K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.67M | SH | $14.11M 5.33% | 1.67M | 0.00 | 0.00 |
CARGO THERAPEUTICS INCSOLE | COM | 856.85K | SH | $14.07M 5.32% | 856.85K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.13M | SH | $13.29M 5.02% | 1.13M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 760.94K | SH | $12.46M 4.71% | 760.94K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 164.77K | SH | $9.75M 3.68% | 164.77K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 419.65K | SH | $8.62M 3.26% | 419.65K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 627.76K | SH | $8.30M 3.14% | 627.76K | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | COM CL A | 1.11M | SH | $7.26M 2.74% | 1.11M | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 713.54K | SH | $7.08M 2.67% | 713.54K | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 249.61K | SH | $6.26M 2.36% | 249.61K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 593.31K | SH | $6.11M 2.31% | 593.31K | 0.00 | 0.00 |
ITEOS THERAPEUTICS INCSOLE | COM | 367.43K | SH | $5.45M 2.06% | 367.43K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 1.14M | SH | $5.09M 1.92% | 1.14M | 0.00 | 0.00 |
NEUMORA THERAPEUTICS INC.SOLE | COM | 390.08K | SH | $3.83M 1.45% | 390.08K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 152.18K | SH | $3.56M 1.34% | 152.18K | 0.00 | 0.00 |
LONGBOARD PHARMACEUTICALS INSOLE | COM | 71.44K | SH | $1.93M 0.73% | 71.44K | 0.00 | 0.00 |
RAPPORT THERAPEUTICS INCSOLE | COM | 70K | SH | $1.63M 0.62% | 70K | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 47.66K | SH | $1.62M 0.61% | 47.66K | 0.00 | 0.00 |
Page 1 of 2